AAAhmed Abdelsalam

Ahmed Abdelsalam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ahmed Abdelsalam has a total of 360 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Beyond the Catheter: Contemporary Aspiration Pump Systems in Neurointerventional Stroke Therapy

    by Sai Sanikommu, Connor Berger, Alejandro N. Santos, Caleigh Roach, Victor M. Lu, Emade Jaman, Sima M. Vazquez, Ahmed Abdelsalam, Romil Singh, Tiffany Eatz, et al.

    Acute ischemic stroke is the greatest cause of morbidity and mortality among cerebrovascular pathologies. Over time, several therapeutic options have been developed for treating patients with stroke, including IV r-tPA (intravenous recombinant tissue-type plasminogen activator) and IV-TNK (intravenous tenecteplase) thrombolysis, and endovascular mechanical thrombectomy, with the latter showing favorable recanalization rates. Stent retrievers and mechanical aspiration, the 2 types of mechanical thrombectomy, are used for acute ischemic stroke due to large-vessel occlusions. The first reported aspiration thrombectomy dates back to 2002, during which a 50 mL syringe was used to generate negative pressure and aspirate a clot. Since then, extensive research and development have transformed aspiration thrombectomy. Penumbra’s first system paved the way for present-day aspiration systems in neurointerventional surgery, such as the Penumbra engine and Thunderbolt aspiration systems. Ongoing innovations have focused on improving access to challenging vascular locations and enabling the removal of large thrombi. Over time, aspiration techniques have also evolved. However, despite successful first-pass complete revascularization, a subset of patients continues to experience poor functional outcomes, highlighting the multifactorial nature of stroke recovery. In this review, we outline in detail the historical development of aspiration pump systems in neuroendovascular surgery, describe the different systems and their technical characteristics, highlight the clinical trials evaluating their efficacy, with particular attention to distinctions between devices, and discuss avenues for future growth.

  • Predictors of Intracranial Aneurysm Residual Filling After Treatment With Flow Diversion at Early Follow-up: A Multicenter Experience of 2277 Patients

    by Joshua D. Burks, Ahmed Abdelsalam, Evan M. Luther, Kara M. Christopher, Michael A. Silva, Pascal Jabbour, Sami Al Kasab, Michael R. Levitt, Sai Sanikommu, Adib A. Abla, et al.

    BACKGROUND AND OBJECTIVES: Flow-diverting stents (FDSs) have improved treatment options for intracranial aneurysms. Although FDS have proven successful in treating aneurysms that would previously have required complex microsurgical or endovascular repairs, treatment failures remain a concern. In this multicenter study, we aim to analyze the predictors of residual aneurysmal filling at early angiographic follow-up. METHODS: A retrospective analysis of a prospectively maintained neuroendovascular database at 14 high-volume US centers was conducted for all patients who underwent FDS placement for intracranial aneurysms between 2011 and 2019. Aneurysms were graded on the O'Kelly-Marotta scale (OKM). RESULTS: A total of 2277 patients underwent FDS embolization for intracranial aneurysms during the study period. The patient's mean age was 55 (SD ± 13.5) years, and 82% were female. The median maximal aneurysm diameter was 6.7 mm (IQR 4.10-11 mm). Complete aneurysm obliteration (OKM grade 4) occurred in 1109 patients (68%), and 146 (9%) were OKM grade 3, 188 (12%) were OKM grade 2, and 174 (11%) were OKM grade 1. In the adjusted multivariate analysis, individuals in the 65-74 years and 75+ years age groups had significantly increased risk of residual aneurysm filling at 6-month follow-up compared with the 18-44 years age group (odds ratio [OR] 1.92 (95% CI: 1.33-2.78) and 2.92 (95% CI: 1.79-4.77), respectively). Aneurysms arising from the superior cerebellar artery, the basilar artery, and the carotid terminus were more likely to have a residual filling (OR 12.6, 95% CI: 1.39–14.7; OR 4.27, 95% CI: 1.39–14.7; OR 3.16, 95% CI: 1.24–8.06, respectively). CONCLUSION: As the utilization of FDS for intracranial aneurysms becomes more widespread, the efficacy of aneurysm obliteration needs to be assessed. Our results indicate that several patient-dependent factors, such as age, aneurysm location, and size, predict the likelihood of residual aneurysm filling 6 months post-treatment.


  • Open Access

    From data to impact: The societal contributions of neurological and neurosurgical national registries

    by Tiffany Eatz, Chase DeLong, Ashley R. Metzler, Neil Patel, Ian A. Ramsay, Sai Sanikommu, Soumya Shrigiri, Ahmed Abdelsalam, Luis Guada, Michael A. Silva, et al.

  • The Ballast radial access system in neuroendovascular procedures: A multicenter investigation of 138 patients

    by Ahmed Abdelsalam, Sai Sanikommu, Luis Guada, Ian A. Ramsay, Soumya Shrigiri, Michael A. Silva, Victor M. Lu, Kara M. Christopher, Ahmad Sweid, Joshua H. Weinberg, et al.


  • Radial vs femoral access in mechanical thrombectomy: Implications for clinical practice – A systematic review and meta-analysis

    by Ali Mortezaei, Ahmed Abdelsalam, Alireza Oladaskari, Ahmed Y. Azzam, Christina Tran Meng, Sai Sanikommu, Tiffany Eatz, Michael A. Silva, Luis Guada, Caleigh S. Roach, et al.


  • The utility of the PK papyrus covered stent in neurointervention: A prospective study on safety, efficacy, and aneurysm occlusion rates

    by Ahmed Abdelsalam, Andrew Yu, Sai Sanikommu, Luis Guada, Soumya Shrigiri, Vasu Saini, Hayes B. Fountain, Turki Elarjani, Emade Jaman, Carolina Benjamin, et al.


  • Microsurgical clipping of ruptured basilar artery perforator aneurysms in the endovascular era: A single-center experience

    by Ahmed Abdelsalam, Soliman Oushy, Alex Lu, Ian A. Ramsay, Jacob Young, Sai Sanikommu, Lorenzo Rinaldo, Atakan Orscelik, Soumya Shrigiri, Luis E. Savastano, et al.


  • Long-Term (12 Months) Outcomes of Endovascular Thrombectomy for Large Core Stroke: A Meta‐Analysis of SELECT2, TESLA, TENSION, and LASTE Trials

    by Ali Mortezaei, Muhammed Amir Essibayi, Ahmed Abdelsalam, Joshua Hanna, Redi Rahmani, David J. Altschul, Robert M. Starke

    BACKGROUND: Endovascular thrombectomy (EVT) has demonstrated benefits over standard medical care (MC) in randomized controlled trials (RCTs) for patients with large vessel occlusion (LVO) and large infarct territory at 90 days. However, conflicting evidence exists regarding long-term safety and efficacy of EVT in these populations. PURPOSE: To evaluate the clinical benefits of EVT in patients with large-core infarction through meta-analysis of high-quality RCT evidence with up to one-year follow-up. DATA SOURCES: PubMed/MEDLINE, Web of Science, and Scopus databases. STUDY SELECTION: RCTs involving patients with confirmed LVO and Alberta Stroke Program Early CT Score (ASPECTS) of ≤5, comparing EVT plus MC versus MC alone, with long-term outcome data. DATA ANALYSIS: Meta-analysis of long-term functional and safety outcomes with subgroup analysis comparing long-term (≤1 year) versus short-term (≤90 days) data on functional outcomes, imaging modalities, and presentation window. Leave-one-out sensitivity analysis was performed to resolve heterogeneity. DATA SYNTHESIS: Four RCTs comprising 1229 patients (49% female) were included. EVT demonstrated significant superiority over MC in functional independence (mRS0-2) (RR 3.91, 95% CI 2.7-5.66; P<0.001), mortality (RR 0.84, 95% CI 0.75-0.95; P=0.005), overall survival (mRS0-5) (RR 1.17, 95% CI 1.05-1.31; P=0.005), and quality of life (SMD 0.55, 95% CI 0.32-0.8; P<0.001) with up to one-year follow-up. No significant differences in complication rates were observed except for higher extra-cerebral thromboembolic events in the EVT group (RR 7.94, 95% CI 1.01-62.2; P=0.048). LIMITATIONS: Study limited to RCT data with potential variations in thrombectomy techniques and patient selection criteria across trials. CONCLUSIONS: In patients with ischemic stroke due to LVO with established large core infarct, EVT plus MC showed significant long-term benefits in functional outcomes, survival, and quality of life compared to MC alone. ABBREVIATIONS: EVT = endovascular thrombectomy; MC = medical care; LVO = large vessel occlusion; ASPECTS = Alberta Stroke Program Early CT Score; RCTs = randomized controlled trials; RR = risk ratio; CI = confidence interval; SMD = standardized mean difference; mRS = modified Rankin Scale; sICH = symptomatic intracranial hemorrhage; PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analyses; HR = hazard ratio; ROB2 = Risk of Bias 2; NIHSS = National Institutes of Health Stroke Scale.


  • Top Cited Papers

    Outcomes of Adjunct Emergent Stenting Versus Mechanical Thrombectomy Alone: The RESCUE-ICAS Registry

    by Sami Al Kasab, Eyad Almallouhi, Mohammad Jumaa, Violiza Inoa, Francesco Capasso, Michael Nahhas, Robert M. Starke, Isabel Fragata, Matthew Bender, Krisztina Moldovan, et al.

    BACKGROUND: Underlying intracranial stenosis is the most common cause of failed mechanical thrombectomy in patients with acute ischemic stroke with large vessel occlusion. Adjunct emergent stenting is sometimes performed to improve or maintain reperfusion, despite limited data regarding its safety or efficacy. METHODS: We conducted a prospective multicenter observational international cohort study. Patients were enrolled between January 2022 and December 2023 at 25 thrombectomy-capable centers in North America, Europe, and Asia. Consecutive patients treated with mechanical thrombectomy were included if they were identified as having underlying intracranial stenosis, defined as 50% to 99% residual stenosis of the target vessel or intraprocedural reocclusion. The primary outcome was functional independence, defined as a modified Rankin Scale score of 0 to 2 at 90 days. After applying inverse probability of treatment weighting based on propensity scores, we compared outcomes among patients who underwent adjunct emergent intracranial stenting (stenting) versus those who received mechanical thrombectomy alone. RESULTS: A total of 417 patients were included: 218 patients treated with mechanical thrombectomy alone (168 anterior circulation) and 199 with mechanical thrombectomy plus stenting (144 anterior circulation). Patients in the stenting group were less likely to be non-Hispanic White (51.8% versus 62.4%, P =0.03) and less likely to have diabetes (33.2% versus 43.1%, P =0.037) or hyperlipidemia (43.2% versus 56%, P =0.009). In addition, there was a lower rate of IV thrombolysis use in the stenting group (18.6% versus 27.5%, P =0.03). There was a higher rate of successful reperfusion (modified Treatment in Cerebral Infarction score ≥2B) in the stenting versus mechanical thrombectomy–alone group (90.9% versus 77.9%, P P =0.005). The overall complication rate was higher in the stenting group (12.6% versus 5%, P =0.006), but there was not a significant difference in the rate of symptomatic hemorrhage (9% versus 5.5%, P =0.162). Functional independence at 90 days was significantly higher in the stenting group (42.2% versus 28.4%, adjusted odds ratio, 2.67 [95% CI, 1.66–4.32]). CONCLUSIONS: In patients with underlying stenosis who achieved reperfusion with mechanical thrombectomy, adjunct emergent stenting was associated with better functional outcome without a significantly increased risk of symptomatic hemorrhage. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05403593.


  • Effect of SARS-CoV-2 Infection on Endovascular Thrombectomy Outcomes—Data from the Florida Stroke Registry

    by Hayes B Fountain, Ian Ramsay, Ruijie Yin, Ahmed Abdelsalam, Michael Silva, David Z Rose, Angus Jameson, Ying Hao, Ayham Alkhachroum, Carolina M Gutierrez, et al.

    BACKGROUND AND PURPOSE: Endovascular thrombectomy outcomes are impacted by changes in stroke systems of care. During the pandemic, SARS-CoV2 positive status had major implications on hospital arrival and treatment models of non-COVID related hospital admissions. Using the Florida Stroke Registry, we compared the rates of in-hospital death and discharge outcomes of patients treated with endovascular thrombectomy who tested positive for SARS-CoV2 infection during their hospitalization. MATERIALS AND METHODS: Data from Get with the Guidelines-Stroke hospitals participating in the Florida Stroke Registry during the COVID pandemic from March 2020 to December 2022 were reviewed to identify endovascular thrombectomy patients with coding for SARS-CoV2 testing during their hospital stay. Associations between SARS-CoV2 status and favorable endovascular thrombectomy outcomes of mRS (0-2) at discharge, discharge to home or rehabilitation centre, symptomatic intracerebral hemorrhage, in-hospital mortality, and independent ambulation at discharge were examined using multivariate logistic regression modeling adjusting for demographics, vascular risk factors, and clinical characteristics. Temporal analyses were used to compare outcomes across the study period. RESULTS: A total of 8,184 patients underwent endovascular thrombectomy (median age 71.1 years, female 50%, mean NIHSS 14), of these, 180 (2.2%) were SARS-CoV2 positive. Compared to SARS-CoV2 negative endovascular thrombectomy patients, those who tested positive were younger, more frequently male, but with comparable stroke severity at presentation. In multivariable analysis, adjusting for baseline differences and confounding variables, there was a 33% lower likelihood of being discharged to home/inpatient rehab (OR=0.67, 95% CI=(0.49-0.93)), 65% higher odds of in-hospital death (OR=1.65, 95% CI=(1.06-2.58)), as well as a 85% less chance of having a high mRS (>2) at discharge (OR=0.15, 95% CI=(0.04-0.60)) for patients with positive SARS-CoV2 infection. However, a similar risk of symptomatic intracerebral hemorrhage was present compared to SARS-CoV2 negative patients (OR=0.97, 95% CI=(0.501.88)). Temporal analysis of SARS-CoV2 positive patients showed no significant differences. CONCLUSIONS: In this large multicenter stroke registry, despite comparable clinical presentation and in-hospital treatment timelines, SARS-CoV2 positive status negatively impacted thrombectomy outcomes. ABBREVIATIONS: AIS = acute ischemic stroke; LVO = large vessel occlusion; EVT = endovascular thrombectomy; FSR = Florida Stroke Registry; sICH = symptomatic intracerebral hemorrhage.